25 Stocks Moving in Wednesday's Pre-Market Session

Gainers

• 17 Education & Technology Group Inc. YQ rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10 million buyback program.
• Rockwell Medical, Inc. RMTI rose 58.6% to $0.7632 in pre-market trading after the company announced results from a study demonstrated no drug-drug interaction between ferric pyrophosphate citrate and unfractionated heparin.
• SPI Energy Co., Ltd. SPI shares rose 20% to $7.38 in pre-market trading after gaining 9% on Tuesday.
• Asia Pacific Wire & Cable Corporation Limited APWC rose 19% to $3.19 in pre-market trading after the company posted a narrower loss for the first half of the year.
• Progenity, Inc. PROG rose 14.7% to $5.55 in pre-market trading. Progenity shares jumped over 39% on Tuesday amid continued retail investor interest on social media.
• Mullen Automotive, Inc. MULN rose 12.6% to $14.80 in pre-market trading after gaining 11% on Tuesday.
• Canoo Inc. GOEV rose 12.6% to $11.77 in pre-market trading. Canoo shares surged around 24% on Tuesday after the company said it will accelerate its advanced manufacturing production in the US to begin before Q4.
• Lucid Group, Inc LCID shares rose 11.1% to $61.82 in pre-market trading. Lucid Group shares jumped 24% on Tuesday after the company announced Q3 financial results.
• Camber Energy, Inc. CEI rose 10.8% to $1.23 in pre-market trading after gaining around 7% on Tuesday.
• Bone Biologics Corporation BBLG rose 10.6% to $4.28 in pre-market trading. Bone Biologics recently reported a Q3 loss of $0.17 per share.
• Vir Biotechnology, Inc. VIR shares rose 9.6% to $36.62 in pre-market trading. GlaxoSmithKline and Vir Biotechnology recently announced topline data from COMET-TAIL Phase 3 trial evaluating sotrovimab delivered via Intramuscular (IM) administration compared to IV administration in high-risk COVID-19 patients.
• Chembio Diagnostics, Inc. CEMI rose 8.3% to $2.23 in pre-market trading after the company announced the submission of an Emergency Use Authorization application to the FDA for the new DPP SARS-CoV-2 Antigen test.
• Lion Group Holding Ltd. LGHL rose 7.5% to $2.29 in pre-market trading after gaining 5% on Tuesday.
• Innoviz Technologies Ltd. INVZ rose 7.2% to $6.35 in pre-market trading. Innoviz Technologies, last week, reported a Q3 loss of $0.20 per share on sales of $2.10 million.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Cyclo Therapeutics, Inc. CYTH fell 14.2% to $6.30 in pre-market trading after the company reported pricing of $11.7 million underwritten public offering of common stock.
• Atea Pharmaceuticals, Inc. AVIR fell 12.7% to $9.92 in pre-market trading after Roche Holding AG terminated a partnership with the company to jointly develop a COVID-19 antiviral pill.
• SOC Telemed, Inc. TLMD shares fell 11.5% to $2.63 in pre-market trading. SOC Telemed, last week, reported better-than-expected Q3 EPS and sales results and raised FY21 guidance.
• DLocal Limited DLO shares fell 8.7% to $42.90 in pre-market trading after reporting downbeat quarterly earnings.
• Creative Realities, Inc. CREX fell 8.2% to $2.25 in pre-market trading. The company recently posted downbeat quarterly sales.
• Altamira Therapeutics Ltd. CYTO shares fell 8.1% to $2.16 in pre-market trading. Altamira Therapeutics recently announced efficacy data from testing its Bentrio nasal spray in vitro against the Delta variant of the SARS-CoV-2 virus.
• ReTo Eco-Solutions, Inc. RETO shares fell 8.1% to $2.51 in pre-market trading after jumping over 48% on Tuesday.
• StoneCo Ltd. STNE fell 7.9% to $29.16 in pre-market trading after the company reported Q3 results.
• Second Sight Medical Products, Inc. EYES fell 7.3% to $3.16 in pre-market trading after jumping 25% on Tuesday.
• Verb Technology Company, Inc. VERB shares fell 6.4% to $1.89 in pre-market trading after the company reported at the market equity offering program.
• iQIYI, Inc. IQ fell 5% to $8.16 in pre-market trading following Q3 results.